BioSpace News Archive

Agilent Technologies Inc. (NYSE: A) announced today that Stefanos Nikolaidis Ph.D. has received the Agilent 2022 Early Career Professor Award.

180 Life Sciences Corp. announced that a team led by researchers at University of Oxford have been awarded a grant from the National Institute for Health and Care Research in the U.K. to conduct a feasibility trial to investigate whether anti-tumor necrosis factor therapy, administered at the time of surgery, can reduce or prevent post operative delirium/cognitive deficit.

Biofrontera Inc., a biopharmaceutical company specializing in the commercialization of dermatological products, announced it has entered into agreements with certain of its holders of its existing warrants for 2,857,143 shares of its common stock, in the aggregate.

Exclugo, the healthcare industry’s provider of “fresher healthcare monitoring,” is pleased to announce a breakthrough in the monitoring of sexual predators seeking employment within the healthcare industry.

Concarlo Therapeutics has hired Vadim Shepel as Chief Business & Operating Officer.

Prolacta Bioscience®, reports that data from a growing body of peer-reviewed clinical studies show a reduced risk of several comorbidities among premature infants who received Prolacta’s 100% human milk-based fortifiers as part of Exclusive Human Milk Diet (Prolacta’s EHMD), compared to premature infants fed cow milk-based fortifiers.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the release of Illumina DRAGEN™ v4.0, its most accurate and comprehensive secondary analysis platform.

Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal engineered muscle tissue (EMT) contractility analysis.

The service has highly supported research related to protein identification, analysis, sequence analysis and characterization of post-translational modifications.

City of Hope, one of the largest cancer research and treatment organizations in the United States, opens its visionary comprehensive cancer center in Orange County, California, creating a national model for delivering breakthrough research and pioneering treatments.